This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (146)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Lipids and Lipid Disorders  • Nutritional and Metabolic Disorders, Other  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Mordchai Ravid, MD; David Brosh, MD; Dorit Ravid-Safran, MD; Zohar Levy, MD; Rita Rachmani, MD

Arch Intern Med. 1998;158:998-1004.

Background  The control of hyperglycemia is of major importance in the treatment of patients with type 1 diabetes mellitus. However, there is no consensus about the required degree of metabolic control in patients with type 2 diabetes mellitus and about the role of hyperglycemia in diabetic nephropathy and in the development of atherosclerosis in relation to other risk factors.

Patients and Methods  A prospective, long-term follow-up study was conducted on 574 patients, aged 40 to 60 years, with recent onset of type 2 diabetes mellitus. Patients were initially normotensive and had normal renal function and a normal urinary albumin excretion rate (<30 mg/24 h). The patients were followed up for 2 to 9 years (mean ± SD, 7.8 ± 0.9 years). Levels of hemoglobin A_1c and plasma lipids, mean blood pressure, and body mass index (calculated as the weight in kilograms divided by the square of the height in meters) were determined periodically. Cigarette smoking and socioeconomic status were recorded. Renal status was evaluated by the logarithm of the final urinary albumin excretion rate and by the decline in reciprocal creatinine values. Definite clinical events including death, nonfatal myocardial infarction, angina pectoris, congestive heart failure, and peripheral vascular disease were recorded.

Results  At the end of the study the urinary albumin excretion rate remained normal (<30 mg/24 h) in 373 patients (65%), 111 (19%) had microalbuminuria (30-300 mg/24 h), and 90 (16%) had overt albuminuria (>300 mg/24 h). Logistic regression models demonstrated that the correlation between hemoglobin A_1c levels and the risk of albuminuria is exponential. Multiple logistic regression analysis indicated that levels of total cholesterol, mean blood pressure, and hemoglobin A_1c were the main factors associated with the decrease in renal function and with the increase in albuminuria. The combination of values higher than the 50th percentile of all 3 factors defined a high-risk patient population. These high-risk patients had an odds ratio of 43 (95% confidence interval, 25-106) for microalbuminuria and 15 (95% confidence interval, 9-25) for clinical events related to arteriosclerosis compared with the rest of the group. Low levels of high-density lipoprotein, body mass index, cigarette smoking, low socioeconomic status, and male sex were all significantly associated with diabetic nephropathy, as well as with the manifestations of arteriosclerosis.

Conclusions  The combination of blood pressure values in the high-normal range with moderately elevated levels of total cholesterol and hemoglobin A_1c defines a high-risk group for the progression to diabetic nephropathy and for clinical events related to arteriosclerotic cardiovascular disease.

From the Departments of Medicine (Drs Ravid, Levy, and Rachmani) and Obstetrics and Gynecology (Dr Ravid-Safran), Tel-Aviv University and Meir Hospital, Kfar-Sava, and the Department of Cardiology, Municipal Medical Center, Tel-Aviv (Dr Brosh), Israel.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sex, diabetes and the kidney
Maric
Am. J. Physiol. Renal Physiol. 2009;296:F680-F688.
ABSTRACT | FULL TEXT  

Statin Use Is Associated with Prolonged Survival of Renal Transplant Recipients
Wiesbauer et al.
J. Am. Soc. Nephrol. 2008;19:2211-2218.
ABSTRACT | FULL TEXT  

Effects of albuminuria and renal dysfunction on development of dyslipidaemia in type 2 diabetes--the Hong Kong Diabetes Registry
Yang et al.
Nephrol Dial Transplant 2008;23:2834-2840.
ABSTRACT | FULL TEXT  

Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association
American Diabetes Association
Diabetes Care 2008;31:S61-S78.
FULL TEXT  

Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats
Sun et al.
Am. J. Physiol. Renal Physiol. 2007;292:F1681-F1690.
ABSTRACT | FULL TEXT  

Risk Imparted by Various Parameters of Smoking in Japanese Men With Type 2 Diabetes on Their Development of Microalbuminuria: Analysis from the Tsukuba Kawai Diabetes Registry
Saito et al.
Diabetes Care 2007;30:1286-1288.
FULL TEXT  

Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association
American Diabetes Association
Diabetes Care 2007;30:S48-S65.
FULL TEXT  

Identifying Genetic Susceptibilities to Diabetes-related Complications among Individuals at Low Risk of Complications: An Application of Tree-Structured Survival Analysis
Costacou et al.
Am J Epidemiol 2006;164:862-872.
ABSTRACT | FULL TEXT  

Nutrition Recommendations and Interventions for Diabetes-2006: A position statement of the American Diabetes Association.
American Diabetes Association
Diabetes Care 2006;29:2140-2157.
FULL TEXT  

Prevention and Treatment of Diabetic Renal Disease in Type 2 Diabetes: The BENEDICT Study
Remuzzi et al.
J. Am. Soc. Nephrol. 2006;17:S90-S97.
ABSTRACT | FULL TEXT  

Lipids and Renal Disease
Trevisan et al.
J. Am. Soc. Nephrol. 2006;17:S145-S147.
ABSTRACT | FULL TEXT  

Comparison of Methods for Determining Renal Function Decline in Early Autosomal Dominant Polycystic Kidney Disease: The Consortium of Radiologic Imaging Studies of Polycystic Kidney Disease Cohort
Rule et al.
J. Am. Soc. Nephrol. 2006;17:854-862.
ABSTRACT | FULL TEXT  

Association between tumour necrosis factor-{alpha} G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients
Wang et al.
Nephrol Dial Transplant 2005;20:2733-2738.
ABSTRACT | FULL TEXT  

Applying the 2005 Canadian Hypertension Education Program recommendations: 5. Therapy for patients with hypertension and diabetes mellitus
Tobe et al.
CMAJ 2005;173:1154-1157.
FULL TEXT  

Effect of Hepatic Lipase -514C->T Polymorphism and Its Interactions With Apolipoprotein C3 -482C->T and Apolipoprotein E Exon 4 Polymorphisms on the Risk of Nephropathy in Chinese Type 2 Diabetic Patients
Baum et al.
Diabetes Care 2005;28:1704-1709.
ABSTRACT | FULL TEXT  

Prospective Study of Lipoprotein(a) as a Risk Factor for Deteriorating Renal Function in Type 2 Diabetic Patients With Overt Proteinuria
Song et al.
Diabetes Care 2005;28:1718-1723.
ABSTRACT | FULL TEXT  

Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
Gross et al.
Diabetes Care 2005;28:164-176.
ABSTRACT | FULL TEXT  

Dissociation of renal TGF-{beta} and hypertrophy in female rats with diabetes mellitus
Lane et al.
Am. J. Physiol. Renal Physiol. 2004;287:F1011-F1020.
ABSTRACT | FULL TEXT  

The renoprotective effects of structured care in a clinical trial setting in type 2 diabetic patients with nephropathy
Leung et al.
Nephrol Dial Transplant 2004;19:2519-2525.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy
Fong et al.
Diabetes Care 2004;27:2540-2553.
FULL TEXT  

From Finland to Fatland: Beneficial Effects of Statins for Patients with Chronic Kidney Disease
Afzali et al.
J. Am. Soc. Nephrol. 2004;15:2161-2168.
ABSTRACT | FULL TEXT  

Optimizing Therapy in the Diabetic Patient with Renal Disease: Antihypertensive Treatment
Deferrari et al.
J. Am. Soc. Nephrol. 2004;15:S6-11.
ABSTRACT | FULL TEXT  

Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)
Svensson et al.
Diabetes Care 2003;26:2903-2909.
ABSTRACT | FULL TEXT  

The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency
Knight et al.
ANN INTERN MED 2003;138:460-467.
ABSTRACT | FULL TEXT  

Halting the Progression of Chronic Nephropathy
Campbell et al.
J. Am. Soc. Nephrol. 2002;13:S190-195.
ABSTRACT | FULL TEXT  

Microalbuminuria in diabetes mellitus
Tobe et al.
CMAJ 2002;167:499-503.
FULL TEXT  

Longitudinal Association of Glycemia and Microalbuminuria: The Framingham Offspring Study
Meigs et al.
Diabetes Care 2002;25:977-983.
ABSTRACT | FULL TEXT  

Risk Factors for Microalbuminuria and Macroalbuminuria in Type 2 Diabetic Patients: A 9-year follow-up study
Murussi et al.
Diabetes Care 2002;25:1101-1103.
FULL TEXT  

Smoking and proteinuria impair vasodilatory response of intrarenal arteries to nitroglycerine in patients with type 2 diabetes mellitus
Matsumoto et al.
Nephrol Dial Transplant 2002;17:608-613.
ABSTRACT | FULL TEXT  

Effect of a Chicken-Based Diet on Renal Function and Lipid Profile in Patients With Type 2 Diabetes: A randomized crossover trial
Gross et al.
Diabetes Care 2002;25:645-651.
ABSTRACT | FULL TEXT  

Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: Rationale and Design
Shea et al.
J. Am. Med. Inform. Assoc. 2002;9:49-62.
ABSTRACT | FULL TEXT  

Glycohemoglobin: A Primary Predictor of the Development or Reversal of Complications of Diabetes Mellitus
Krishnamurti and Steffes
Clin. Chem. 2001;47:1157-1165.
ABSTRACT | FULL TEXT  

Complications of diabetes: renal disease and promotion of self-management
Melville et al.
Qual Saf Health Care 2000;9:257-263.
FULL TEXT